Simon Keady, EU Market Access Lead - Biosimilars at Biogen
Biogen Logo

Simon Keady


EU Market Access Lead - Biosimilars
Biogen
Biosimilars Commercialisation Summit Agenda 2019

Biosimilars Commercialisation Summit Agenda 2019

View Content

Conference Day One

Wednesday, February 5th, 2020


4:40 PM The Value and Trust Tool Kit

  • Understand the cross-functional roles required to deliver a successful commercial launch
  • Determine what 'value' is and what it means to different stakeholders
  • Identify the requirements for successful partnerships with customers
  • Decide whether price alone delivers success
  • Deliver robust internal benchmarks and measures to qualify success

5:40 PM Panel Discussion: Boosting Patient Access to Biosimilars In Europe

  • Explore the need for collaboration between Payers, Regulators and Industry to enhance patient access to biosimilars in Europe
  • Consider how policy can be utilized as a tool to broaden patient access
  • What does the future hold for the stability of the Biosimilars Market in the EU?

Check out the incredible speaker line-up to see who will be joining Simon.

Download The Latest Agenda